Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search
Table of Contents
Front Matter
Show Items
Automation and Information Technology–Positions
Show Items
Automation and Information Technology–Statements
Show Items
Automation and Information Technology–Guidelines
Show Items
Drug Distribution and Control–Positions
Show Items
Drug Distribution and Control–Guidelines
Show Items
Drug Distribution and Control: Procurement–Guidelines
Show Items
Drug Distribution and Control: Preparation and Handling–Positions
Show Items
Drug Distribution and Control: Preparation and Handling–Guidelines
Show Items
Drug Distribution and Control: Preparation and Handling–Technical Assistance Bulletin
Show Items
Drug Distribution and Control: Distribution–Positions
Show Items
Drug Distribution and Control: Distribution–Statements
Show Items
Drug Distribution and Control: Distribution–Technical Assistance Bulletins
Show Items
Education and Training–Positions
Show Items
Education and Training–Endorsed Document
Show Items
Ethics–Positions
Show Items
Ethics–Statements
Show Items
Ethics–Guideline
Show Items
Ethics–Endorsed Document
Show Items
Formulary Management (Medication-Use Policy Development)–Positions
Show Items
Formulary Management (Medication-Use Policy Development)–Statements
Show Items
Formulary Management (Medication-Use Policy Development)–Guidelines
Show Items
Formulary Management (Medication-Use Policy Development)–Endorsed Document
Show Items
Government, Law, and Regulation–Positions
Show Items
Government, Law, and Regulation–Statements
Show Items
Medication Safety–Positions
Show Items
Medication Safety–Statements
Show Items
Medication Safety–Guidelines
Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Positions
Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Statements
Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Guidelines
Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Positions
Suicide Awareness and Prevention (1901)
Therapeutic Use of Cannabidiol (1910)
Safe Use and Effective Use of IV Promethazine (1831)
Therapeutic and Psychosocial Considerations of Transgender Patients (1718)
Pharmacist’s Leadership Role in Glycemic Control (1719)
Pain Management (1722)
Safe and Effective Therapeutic Use of Invertebrates (1724)
Drug Dosing in Extracorporeal Therapies (1725)
Safety of Intranasal Route as an Alternative Route of Administration (1601)
Stewardship of Drugs with Potential for Abuse (1603)
Appropriate Use of Antipsychotic Drug Therapies (1604)
Safety of Epidural Steroid Injections (1605)
Use of Methadone to Treat Pain (1607)
Controlled Substance Diversion and Patient Access (1614)
Tobacco, Tobacco Products, and Electronic Delivery Systems (1625)
Naloxone Availability (1510)
Safety and Effectiveness of Ethanol Treatment for Alcohol Withdrawal Syndrome (1514)
Chemotherapy Parity (1516)
Documentation of Penicillin Allergy as a Component of Antimicrobial Stewardship (1517)
Prescription Drug Abuse (1526)
Pharmacist’s Role in Urgent and Emergency Situations (1527)
Appropriate Use of Testosterone (1536)
Safe Use of Radiopharmaceuticals (1402)
Safe Use of Fentanyl Transdermal System Patches (1404)
Education About Performance-Enhancing Substances (1305)
Pharmacists’ Role in Immunization (1309)
Pharmacist’s Role in Accountable Care Organizations (1214)
Criteria for Medication Use in Geriatric Patients (1221)
Pharmacist’s Role in Providing Care for an Aging Population (0902)
Pharmacist Role in the Health Care (Medical) Home (0908)
Safe and Effective Use of Heparin in Neonatal Patients (0912)
Pharmacist Support for Dying Patients (0307)
Interventions to Reduce High-Risk Behavior in Intravenous Drug Users (9711)
Medication Therapy and Patient Care: Specific Practice Areas–Statements
Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Guidelines
Show Items
Pharmaceutical Industry: Drug Products, Labeling, and Packaging–Positions
Show Items
Pharmaceutical Industry: Industry: Marketing–Positions
Show Items
Pharmaceutical Industry: Industry: Marketing–Guideline
Show Items
Pharmacy Management–Positions
Show Items
Pharmacy Management–Statements
Show Items
Pharmacy Management–Guidelines
Show Items
Pharmacy Management: Compensation and Reimbursement–Positions
Show Items
Pharmacy Management: Human Resources–Positions
Show Items
Pharmacy Management: Human Resources–Guideline
Show Items
Pharmacy Management: Human Resources–Report
Show Items
Practice Settings–Positions
Show Items
Practice Settings–Guidelines
Show Items
Research–Positions
Show Items
Research–Statement
Show Items
Research–Guidelines
Show Items
ASHP Therapeutic Position Statements
Show Items
ASHP Therapeutic Guidelines
Show Items
Back Matter
Show Items
Naloxone Availability (1510)
in
Best Practices
Editor:
Bruce Hawkins
DOI:
https://doi.org/10.37573/9781585286560.246
Restricted access
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://publications.ashp.org/abstract/book/9781585286560/ch246.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
[44.201.94.236]
44.201.94.236
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
